Estonian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

vaginitis/peavalu

Link salvestatakse lõikelauale
Leht 1 alates 29 tulemused
OBJECTIVE To measure and compare the incidence of adverse events during use of two medicated intrauterine devices (IUDs). METHODS A multicenter prospective 7-year randomized study. METHODS Family planning clinics, primarily in developing countries. METHODS Women age 18 to 38 years at admission,

Leuprorelin and triptorelin: new indication. Preoperative treatment of uterine leiomyoma: no proven value.

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
(1) The reference treatment for uterine leiomyoma with major symptoms is surgery. (2) Leuprorelin and triptorelin, two Gn-RH analogues, are the first drugs to be licensed in France for preoperative treatment of uterine leiomyoma associated with anaemia, when a reduction in the size of the leiomyoma

Skin patch and vaginal ring versus combined oral contraceptives for contraception.

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND The delivery of combination contraceptive steroids from a transdermal contraceptive patch or a contraceptive vaginal ring offers potential advantages over the traditional oral route. The transdermal patch and vaginal ring could require a lower dose due to increased bioavailability and

Multicenter trial of fleroxacin versus ceftriaxone in the treatment of uncomplicated gonorrhea.

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
In a multicenter, randomized, open, comparative trial, patients with uncomplicated gonorrhea were treated with 400 mg of oral fleroxacin or 250 mg of intramuscular ceftriaxone. A total of 458 men and 447 women were enrolled. Of these, 312 men (68%) and 245 women (55%) were evaluable for efficacy.
Patients with unspecific symptoms were sometimes tested for Candida. In case of findings of this yeast-like fungus in their stools they often were labelled with the diagnosis of a "Candida-syndrome". This comprises headache, weakness, flatulence, ravenous appetite for sweets, itching skin and
OBJECTIVE To analyze the physiology of menopause in the context of the age at menopause, its pattern, climacteric symptoms and associated problems of an urban cohort. METHODS Cross-sectional, analytical study. METHODS Four urban sectors of Hyderabad city, from September to October 2004. METHODS In
BACKGROUND Quality of life (QOL) is impaired in functional dyspepsia (FD). Little is known about the effects of different therapies on the QOL profile in patients with this condition. OBJECTIVE The aims of this study were to measure baseline QOL in patients with FD and to assess changes in QOL over

Ertapenem: a review of its use in the management of bacterial infections.

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Ertapenem, a carbapenem antibacterial, has in vitro activity against many Gram- negative (including Enterobacteriaceae) and Gram-positive aerobic and anaerobic bacteria that are commonly associated with various infections.Once-daily parenteral (intravenous or intramuscular) ertapenem 1g was as

Comparative trials of cefaclor AF in uncomplicated cystitis and asymptomatic bacteriuria.

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Two different doses of cefaclor advanced formulation (AF), a new sustained-release formulation of cefaclor, were compared with the regular formulation of cefaclor for efficacy and safety in the treatment of uncomplicated cystitis and asymptomatic bacteriuria. A 7-day course of treatment was used,
In a primary care setting, the efficacy and safety of ciprofloxacin (CIP) 500 mg b.i.d. were compared with those of cefuroxime axetil (CA) 250 mg b.i.d., each given for 10 days, in a nationwide, open, prospective, randomized trial of 1414 adults with acute sinusitis. Patients were enrolled if they

Efficacy and safety of Menorest in two positive-controlled studies.

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
OBJECTIVE To evaluate the safety and efficacy of Menorest 50 in two clinical trials. METHODS Menorest 50 was evaluated in two trials: the first was a parallel-group, randomized double-bind study vs. Premarin 0.625 mg/day in 214 women while the second was a parallel-group, open-label trial versus

Antibiotics for acute bronchitis.

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND Antibiotic treatment of acute bronchitis, which is one of the most common illnesses seen in primary care, is controversial. Most clinicians prescribe antibiotics in spite of expert recommendations against this practice. OBJECTIVE The objective of this review was to assess the effects of

Preparedness of internal medicine and family practice residents for treating common conditions.

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND Although both internal medicine (IM) and family practice (FP) physicians frequently provide care for the same common adult conditions, IM and FP residency programs differ in their training emphases. OBJECTIVE To assess differences in IM and FP residents' self-perceived preparedness to

Treatment of menorrhagia with the levonorgestrel intrauterine system versus endometrial resection.

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
OBJECTIVE Treatment of menorrhagia with levonorgestrel intrauterine system (LNG IUS) and transcervical resection. METHODS An open, therapeutic, randomized study. METHODS Central county hospital specializing in hysteroscopy. METHODS Two parallel groups of 30 subjects each. METHODS Thirty patients had

Contraceptive efficacy and tolerability with a novel combined contraceptive vaginal ring, NuvaRing.

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
NuvaRing is a novel combined contraceptive vaginal ring that releases 15 μg of ethinylestradiol and 120 μg etonogestrel per day. Each ring is used for one cycle, comprising 3 weeks continuous use of the ring followed by a 1-week ring-free period. The contraceptive efficacy and safety of NuvaRing
Liitu meie
facebooki lehega

Kõige täiuslikum ravimtaimede andmebaas, mida toetab teadus

  • Töötab 55 keeles
  • Taimsed ravimid, mida toetab teadus
  • Maitsetaimede äratundmine pildi järgi
  • Interaktiivne GPS-kaart - märgistage ürdid asukohas (varsti)
  • Lugege oma otsinguga seotud teaduspublikatsioone
  • Otsige ravimtaimi nende mõju järgi
  • Korraldage oma huvisid ja hoidke end kursis uudisteuuringute, kliiniliste uuringute ja patentidega

Sisestage sümptom või haigus ja lugege ravimtaimede kohta, mis võivad aidata, tippige ürdi ja vaadake haigusi ja sümptomeid, mille vastu seda kasutatakse.
* Kogu teave põhineb avaldatud teaduslikel uuringutel

Google Play badgeApp Store badge